Trevena Inc. (TRVN)

1.7 +0.02 (+1.19%)

IEX Real-Time Price

March 22, 2019 EST.

Nasdaq Global Select : Healthcare

Prev Close 1.68

Price Open 1.68

Volume: 850,479

Avg Volume: 2.76M

Market Cap: 157M

P/E Ratio -3.95

52 Wk Range 0.3823-3.5783



TRVN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
75.86M
14.43M
1.79
19.02%

2018-09-28
75.86M
7.2M
2.86
9.49%

2018-09-14
75.86M
6.23M
5.08
8.21%

2018-08-31
75.86M
5.95M
5.23
7.85%




TRVN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-08
Q3 2018
BTO
-0.13 (1)
-0.06
0.07

2018-08-02
Q2 2018
N/A
-0.13 (2)
-0.13
0.00

2018-05-03
Q1 2018
N/A
-0.19 (3)
-0.14
0.05

2018-03-14
Q4 2017
N/A
-0.26 (4)
-0.14
0.05

News

Trevena Brings Clarity To Investors (2019-03-22 17:52 SeekingAlpha)

FDA Minutes Bring TRVN Back to Life In my most recent article FDA Minutes To Bring Trevena Back To Life , I discussed how the release of the minutes from the FDA meeting could potentially relaunch Trevena (TRVN) into the public arena as a viable candidate to be next in line for an FDA appro…

 


Statistics

Shares Outstanding: 92.35M

Top 15 Institution Percent: 28.50

Price To Sales: 27.07

Price To Book: 3.78

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -44.13

Return On Equity: -80.84

Profit Margin: N/A

Price History

Beta: 2.60

50-day Moving Avg: 1.24

200-day Moving Avg: 1.29

YTD Change: N/A

5-day Change: 1.80

1-month Change: 18.88

3-month Change: N/A

6-month Change: -12.82

1-year Change: -3.41

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Trevena Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.trevenainc.com

Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.